0001213900-26-047095.txt : 20260423 0001213900-26-047095.hdr.sgml : 20260423 20260423162550 ACCESSION NUMBER: 0001213900-26-047095 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260423 DATE AS OF CHANGE: 20260423 EFFECTIVENESS DATE: 20260423 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Polyrizon Ltd. CENTRAL INDEX KEY: 0001893645 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-581676 FILM NUMBER: 26889013 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: HAPNINA ST 8 CITY: RA'ANANA PROVINCE COUNTRY: L3 ZIP: 4321545 BUSINESS PHONE: 972-54-7979668 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: HAPNINA ST 8 CITY: RA'ANANA PROVINCE COUNTRY: L3 ZIP: 4321545 D 1 primary_doc.xml X0708 D LIVE 0001893645 Polyrizon Ltd. 8 HAPNINA STREET RAANANA L3 ISRAEL 4321545 +972-9-3740120 ISRAEL None None Corporation true Tomer Izraeli POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Executive Officer Director Chief Executive Officer and Director Nir Ben Yosef POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Executive Officer Chief Financial Officer Eyal Ron POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Executive Officer Chief Science Officer Tidhar Turgeman POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Executive Officer Chief Technology Officer Asaf Itzhaik POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Director Oz Adler POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Director Liat Sidi POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Director Yehonatan Zalman Vinokur POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Director Liron Carmel POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Director Biotechnology Decline to Disclose 06b false 2026-04-07 false true true false 0 Aegis Capital Corp. 000015007 None None 1345 Avenue of the Americas 27th Floor New York X1 UNITED STATES 10105 All States false 3499992 3499992 0 The warrants and shares underlying the warrants, were issued in connection with an offering of (i) 87,777 ordinary shares and warrants to purchase 190,000 ordinary shares in a registered direct offering, and (ii) unregistered warrants to purchase 499,999 false 1 280000 0 Aegis Capital Corp. is entitled to a cash placement fee equal to 8.0% of the gross proceeds received in the offering and $75,000 for reasonable legal fees and disbursements for its counsel. 0 The Company intends to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital. false Polyrizon Ltd. /s/ Tomer Izraeli Tomer Izraeli Chief Executive Officer 2026-04-23